Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Change in Acquisitions & Divestments (2016 - 2026)

Dexcom has reported Change in Acquisitions & Divestments over the past 17 years, most recently at $468.2 million for Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 27.99% to $468.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Mar 2026, down 15.73% year-over-year, with the annual reading at $2.2 billion for FY2025, 23.36% down from the prior year.
  • Change in Acquisitions & Divestments was $468.2 million for Q1 2026 at Dexcom, up from $409.6 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $1.1 billion in Q1 2024 and troughed at $241.8 million in Q1 2022.
  • The 5-year median for Change in Acquisitions & Divestments is $638.7 million (2025), against an average of $619.6 million.
  • Year-over-year, Change in Acquisitions & Divestments crashed 69.39% in 2022 and then soared 188.5% in 2023.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $740.0 million in 2022, then decreased by 2.84% to $719.0 million in 2023, then tumbled by 43.64% to $405.2 million in 2024, then rose by 1.09% to $409.6 million in 2025, then rose by 14.31% to $468.2 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Change in Acquisitions & Divestments are $468.2 million (Q1 2026), $409.6 million (Q4 2025), and $466.2 million (Q3 2025).